The DOJ backs Medicare price negotiations amidst a Novartis lawsuit, while President Trump vows to lower U.S. drug costs.

The next round of Medicare's historic drug price negotiations could save billions for seniors taking medications like Ozempic ...

The U.S. Department of Justice has filed an appeals court brief supporting the right of Medicare officials to negotiate ...

China’s share of the global drug development pipeline grew from 3% in 2013 to 28% in 2023, positioning China as the ...

The federal health insurance program has selected 15 additional drugs covered by Medicare Part D for its next round of price ...

As pharmaceutical companies prepare to meet with the Trump administration to negotiate drug prices, CVS Health (CVS) ...

President Donald Trump will meet with major drugmakers' executives to discuss drug pricing and insurance changes. Key topics ...

U.S. President Donald Trump is set to meet with top pharmaceutical executives on Thursday, a White House official confirmed. The discussions will focus on Medicare drug price negotiations, pharmacy ...

U.S. President Donald Trump will meet on Thursday with chief executives from major drugmakers, a White House official ...

Pharmacy benefits managers, or PBMs, are meant to act as a middleman between drug manufacturers and insurance companies to ...

Debate over whether or not the Affordable Care Act, commonly known as Obamacare, worked and how President Trump's executive ...

While St. Luke’s is not named in the lawsuit, the matter gives an inside glimpse into the competition between the two health ...